| 000 | 01773 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250514204013.0 | ||
| 264 | 0 | _c20041116 | |
| 008 | 200411s 0 0 spa d | ||
| 022 | _a0211-6995 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRobles, N R | |
| 245 | 0 | 0 |
_a[Lercanidipine in diabetic patients with renal failure]. _h[electronic resource] |
| 260 |
_bNefrologia : publicacion oficial de la Sociedad Espanola Nefrologia _c2004 |
||
| 300 |
_a338-43 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadverse effects |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xadverse effects |
| 650 | 0 | 4 |
_aCreatinine _xmetabolism |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xcomplications |
| 650 | 0 | 4 |
_aDihydropyridines _xadverse effects |
| 650 | 0 | 4 |
_aEdema _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xetiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProteinuria _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPastor, L | |
| 700 | 1 | _aManjón, M | |
| 700 | 1 | _aOcón, J | |
| 700 | 1 | _aGómez Campderá, F | |
| 700 | 1 | _aHerrera, J | |
| 700 | 1 | _aVillatoro, J | |
| 700 | 1 | _aCalls, J | |
| 700 | 1 | _aTorrijos, J | |
| 700 | 1 | _aRodríguez Villareal, I | |
| 700 | 1 | _aRodríguez Martínez, M A | |
| 700 | 1 | _aMéndez, M L | |
| 700 | 1 | _aMorey, A | |
| 700 | 1 | _aMartínez Fernández, J | |
| 700 | 1 | _aMarco, J | |
| 700 | 1 | _aLiébana, A | |
| 700 | 1 | _aRincón, B | |
| 700 | 1 | _aTornero, F | |
| 773 | 0 |
_tNefrologia : publicacion oficial de la Sociedad Espanola Nefrologia _gvol. 24 _gno. 4 _gp. 338-43 |
|
| 999 |
_c15147727 _d15147727 |
||